The latest leukaemia news
Viagra and plerixafor show promise for use in bone marrow transplants
Researchers at UC Santa Cruz have demonstrated a new, rapid method to obtain donor stem…
Browsing: Leukaemia
Exploring the risk of ALL in children with Down syndrome
Acute lymphoblastic leukaemia (ALL), is the most common childhood cancer. Children with trisomy 21 (Down…
First CAR T-cell therapy targeting B cell-activating factor receptor eradicates blood cancers
The first CAR T cell therapy targeting the B cell-activating factor receptor on cancerous cells…
The potential of antihistamines in causing the death of leukaemic stem cells
Acute myeloid leukaemia (AML) has one of the worst prognosis of all leukaemias. Its treatment with chemotherapy…
Drug combo heralds major shift in chronic lymphocytic leukaemia treatment
A combination of two drugs keeps patients with chronic lymphocytic leukaemia disease-free and alive longer…
Hidden chemistry in flowers shown to kill cancer cells
Researchers at the University of Birmingham have shown that it’s possible to produce a compound…
New drug provides hope for babies with aggressive acute lymphoblastic leukaemia
A breakthrough new drug is providing hope to tiny babies at risk of dying from…
A heart failure drug to treat leukaemia: a promising new therapeutic approach
Canadian researchers followed their intuition that a drug initially intended for heart failure could be…
EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously untreated patients with chronic lymphocytic leukaemia and coexisting comorbidities
The current standard of care for patients with chronic lymphocytic leukaemia (CLL) and coexisting conditions…
EHA 2019: Genomic evidence of residual disease in patients in remission prior to stem cell transplant; fate or opportunity for early intervention?
Acute myeloid leukaemia (AML) is a rare, highly fatal blood cancer. Allogeneic haematopoietic cell transplantation…